About this source
- Kind
- Research
- Design
- Human clinical trial
- Population
- Human, healthy male volunteers
- Sample size
- 8 per dose level, 5 dose levels (approx. 40 total)
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 August 2026
Limitations
Single study, healthy men only, acute-dosing design, not independently replicated.
Cited in
Healthy male pharmacokinetic study
Ipamorelin · Research finding
Limited
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.